Purchase Order 75F40122P00034

Award Date 1/18/22
Potential Completion Date 3/18/22
Potential Value $354K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Boston, MA 02210, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' Food and Drug Administration awarded a $104,500 firm fixed price purchase order to Emulate Inc., doing business as Emulate, for the procurement of five liver human emulation system 24 pack quad liver chip kits. The place of performance will be Emulate's facilities in Boston, Massachusetts. The period of performance is one year, from June 27, 2023 through June 26, 2024. This contract has a total small business set aside designation. The liver chip kits...
The Department of Health and Human Services Food and Drug Administration awarded a $213,100 firm fixed price purchase order to Emulate Inc. of Boston, Massachusetts. The contract will provide a human emulation system including an ORB-HM1 hub module, two used ZOE-CM2 culture modules, and one new ZOE-CM2 culture module with a one year warranty. Additionally, a service agreement will cover maintenance of the three used items for one year. Per the sole source solicitation, Emulate will satisfy the...
The Department of Health and Human Services Food and Drug Administration awarded a $149,130 firm fixed price purchase order to Emulate Inc., doing business as Emulate, for the delivery of a CDER-2023-117371-ZOE MODULE (ZOE-CM2) WITH AN ORB HUB (ORB-HM1) MCMI23 - ROBUST ORGAN-ON-A-CHIP SYSTEM FOR BIOASSAY DEVELOPMENT. This award responds to Solicitation 75F40123Q00376 which sought a robust organ-on-a-chip system to support the FDA's bioassay development work. Place of performance will be...
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order contract to Emulate Inc., doing business as Emulate, a for-profit organization. The $200,300.00 contract is for the provision of a human emulation system, which is a set-aside for small businesses. Emulate's organ-on-a-chip technology is designed to model human biology for biomedical research, supporting federal initiatives in areas like personalized medicine, biosurveillance,...
The Food and Drug Administration (FDA) awarded a $48,680.00 firm fixed price purchase order to Emulate Inc., a for-profit small business, for the purchase of Emulate Chip-S1 Basic Research Kits. This contract supports the FDA's regulatory science initiatives and advances the agency's work on non-animal testing approaches. The award has an ultimate completion date of August 21, 2025. Emulate Inc. has previously received federal grants, including a cooperative agreement from the Defense Advanced...
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed-price purchase order contract to Emulate Inc., a for-profit small business, with a potential value of $218,100.00. The contract is for the delivery of two (2) each of the Human Emulation System ZOE Culture Module 2 and two (2) each of the Orb Hub Module. Emulate's organ-on-a-chip technology is designed to model human biology and supports federal initiatives in areas like personalized medicine,...
This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services (HHS), to Emulate Inc., a for-profit small business. The contract, valued at $145,260.00, is for the delivery of Emulate's CHIP-S1 Stretchable Chip, a product in their organ-on-a-chip technology line. This technology supports various FDA and HHS initiatives in areas such as personalized medicine, biosurveillance, infectious disease...
This is a federal contract award from the U.S. Army Research, Development and Engineering Command (RDECOM) to Emulate Inc., a biotechnology company specializing in organ-on-chip technology. The $82,750.02 firm fixed-price purchase order is for the delivery of "LIVER HEALTHY QUAD #CULTURE KITS." Emulate, a for-profit organization based in Boston, Massachusetts, has a history of supplying advanced microphysiological systems and associated services to various federal agencies, primarily...
This firm fixed price purchase order for $144,800 was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Emulate Inc., doing business as Emulate, for the delivery of four ZOE culture module updates from Configuration 1 to Configuration 2. No set-aside designation was used for this procurement. Place of performance will be Emulate's facilities in Boston, Massachusetts. Emulate is a for-profit...
The Department of Health and Human Services Food and Drug Administration awarded a $203,019.58 firm fixed price purchase order to Government Scientific Source Inc. to fulfill a total small business set-aside requirement. The award delivers two Emulate Zoe culture modules, one Orb hub module, and one Orb rack module as requested in the solicitation to continue the agency's microphysiological systems research at its facilities in Silver Spring, Maryland. Government Scientific Source Inc. will...

The Department of Health and Human Services Food and Drug Administration awarded a $354,235 purchase order to Emulate Inc., doing business as Emulate, located in Boston, Massachusetts. The firm fixed price contract is for a Liver Human Emulation System to support the FDA's regulatory review processes. Per the original solicitation, the agency sought to procure a Liver-Chip, Quad-Culture Kits, Zoe Culture Modules, an Orb Hub Module and associated equipment with a simple user interface and small footprint to further the FDA's regulatory science initiatives and advance non-animal testing approaches. The sole source award was made under a total small business set-aside designation. Emulate will deliver various components for replicating human liver functions in vitro to help the FDA modernize regulatory review through alternative methods.

Generated 12/29/23, 4:44 PM